NCT07065773Phase 2Active not recruiting

Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis

Study sponsor: Vanda Pharmaceuticals

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-09Estimated
Enrollment · participants50Estimated
Source updated2026-02-04Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Primary completion date changed

Before: Mar 2026. After: Sep 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source